Our work identified four hub genes, IL6, CXCL8, MMP9, and ATF3, as potential biomarkers for the early diagnosis and treatment of DN, and provided clues to the mechanism of disease development of DN at the transcriptome level. This evidence concerns the gene CXCL8 and liver dysplastic nodule.